Annual Interest Expense
$5.81 M
-$1.45 M-19.98%
31 December 2023
Summary:
Kala Pharmaceuticals annual interest expense is currently $5.81 million, with the most recent change of -$1.45 million (-19.98%) on 31 December 2023. During the last 3 years, it has fallen by -$2.77 million (-32.31%). KALA annual interest expense is now -32.31% below its all-time high of $8.59 million, reached on 31 December 2020.KALA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$1.48 M
+$20.00 K+1.37%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly interest expense is currently $1.48 million, with the most recent change of +$20.00 thousand (+1.37%) on 30 September 2024. Over the past year, it has increased by +$19.00 thousand (+1.30%). KALA quarterly interest expense is now -33.03% below its all-time high of $2.21 million, reached on 30 June 2022.KALA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$5.86 M
+$19.00 K+0.33%
30 September 2024
Summary:
Kala Pharmaceuticals TTM interest expense is currently $5.86 million, with the most recent change of +$19.00 thousand (+0.33%) on 30 September 2024. Over the past year, it has dropped by -$64.00 thousand (-1.08%). KALA TTM interest expense is now -31.89% below its all-time high of $8.60 million, reached on 31 March 2021.KALA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.0% | +1.3% | -1.1% |
| 3 y3 years | -32.3% | -28.7% | -30.9% |
| 5 y5 years | +75.4% | -32.2% | -30.5% |
KALA Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.3% | at low | -33.0% | +4.6% | -30.9% | +1.1% |
| 5 y | 5 years | -32.3% | +75.4% | -33.0% | +4.6% | -31.9% | +1.1% |
| alltime | all time | -32.3% | +862.6% | -33.0% | +694.6% | -31.9% | +2920.1% |
Kala Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.48 M(+1.4%) | $5.86 M(+0.3%) |
| June 2024 | - | $1.46 M(+0.2%) | $5.84 M(+0.8%) |
| Mar 2024 | - | $1.46 M(-0.9%) | $5.79 M(-0.3%) |
| Dec 2023 | $5.81 M(-20.0%) | $1.47 M(+0.6%) | $5.81 M(-1.8%) |
| Sept 2023 | - | $1.46 M(+3.3%) | $5.92 M(+0.2%) |
| June 2023 | - | $1.41 M(-4.1%) | $5.91 M(-11.8%) |
| Mar 2023 | - | $1.47 M(-6.5%) | $6.71 M(-7.7%) |
| Dec 2022 | $7.27 M(-13.3%) | $1.58 M(+9.0%) | $7.27 M(-6.4%) |
| Sept 2022 | - | $1.45 M(-34.4%) | $7.76 M(-7.4%) |
| June 2022 | - | $2.21 M(+8.5%) | $8.39 M(+1.4%) |
| Mar 2022 | - | $2.04 M(-2.0%) | $8.27 M(-1.3%) |
| Dec 2021 | $8.38 M(-2.4%) | $2.08 M(+0.2%) | $8.38 M(-1.1%) |
| Sept 2021 | - | $2.07 M(-0.9%) | $8.47 M(-1.0%) |
| June 2021 | - | $2.09 M(-2.3%) | $8.56 M(-0.5%) |
| Mar 2021 | - | $2.14 M(-1.3%) | $8.60 M(+0.2%) |
| Dec 2020 | $8.59 M | $2.17 M(+0.6%) | $8.59 M(+0.3%) |
| Sept 2020 | - | $2.16 M(+1.1%) | $8.56 M(-0.3%) |
| June 2020 | - | $2.13 M(+0.3%) | $8.59 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.13 M(-0.8%) | $8.51 M(+0.4%) |
| Dec 2019 | $8.48 M(+155.9%) | $2.15 M(-1.6%) | $8.48 M(+0.5%) |
| Sept 2019 | - | $2.18 M(+5.8%) | $8.44 M(+26.1%) |
| June 2019 | - | $2.06 M(-1.6%) | $6.69 M(+32.7%) |
| Mar 2019 | - | $2.09 M(-0.3%) | $5.04 M(+52.1%) |
| Dec 2018 | $3.31 M(+225.2%) | $2.10 M(+386.1%) | $3.31 M(+105.3%) |
| Sept 2018 | - | $432.00 K(+4.3%) | $1.61 M(+15.8%) |
| June 2018 | - | $414.00 K(+12.8%) | $1.39 M(+17.3%) |
| Mar 2018 | - | $367.00 K(-8.5%) | $1.19 M(+16.6%) |
| Dec 2017 | $1.02 M(+32.9%) | $401.00 K(+89.2%) | $1.02 M(+24.4%) |
| Sept 2017 | - | $212.00 K(+1.9%) | $819.00 K(+3.3%) |
| June 2017 | - | $208.00 K(+5.1%) | $793.00 K(+2.9%) |
| Mar 2017 | - | $198.00 K(-1.5%) | $771.00 K(+0.5%) |
| Dec 2016 | $767.00 K(+27.0%) | $201.00 K(+8.1%) | $767.00 K(+35.5%) |
| Sept 2016 | - | $186.00 K(0.0%) | $566.00 K(+48.9%) |
| June 2016 | - | $186.00 K(-4.1%) | $380.00 K(+95.9%) |
| Mar 2016 | - | $194.00 K | $194.00 K |
| Dec 2015 | $604.00 K | - | - |
FAQ
- What is Kala Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual interest expense year-on-year change?
- What is Kala Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly interest expense year-on-year change?
- What is Kala Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM interest expense year-on-year change?
What is Kala Pharmaceuticals annual interest expense?
The current annual interest expense of KALA is $5.81 M
What is the all time high annual interest expense for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual interest expense is $8.59 M
What is Kala Pharmaceuticals annual interest expense year-on-year change?
Over the past year, KALA annual interest expense has changed by -$1.45 M (-19.98%)
What is Kala Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of KALA is $1.48 M
What is the all time high quarterly interest expense for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly interest expense is $2.21 M
What is Kala Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, KALA quarterly interest expense has changed by +$19.00 K (+1.30%)
What is Kala Pharmaceuticals TTM interest expense?
The current TTM interest expense of KALA is $5.86 M
What is the all time high TTM interest expense for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM interest expense is $8.60 M
What is Kala Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, KALA TTM interest expense has changed by -$64.00 K (-1.08%)